Trinity Biotech plc (NASDAQ: TRIB) announced that its redesigned continuous glucose monitoring sensor achieved accurate glucose readings over a 15-day ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE